V. Sian , J. Sarparanta , A. Hentschel , P. Jonson , A. Roos , S. Natraj Gayathri , B. Udd , M. Savarese , A. Nebbioso
{"title":"271P 探索表观药物雷莫德林对小鼠成肌细胞分化的影响","authors":"V. Sian , J. Sarparanta , A. Hentschel , P. Jonson , A. Roos , S. Natraj Gayathri , B. Udd , M. Savarese , A. Nebbioso","doi":"10.1016/j.nmd.2024.07.089","DOIUrl":null,"url":null,"abstract":"<div><div>Skeletal muscle differentiation is a tightly controlled and elaborated process, that consists of alignment and fusion of myoblasts to form mature myotubes. A growing interest for epigenetics involvement in guiding muscle differentiation raised the attention on epi-modulators as pivotal regulators in this process. Our in vitro study aimed to investigate the potential effects of Remodelin in muscle differentiation. Remodelin is the inhibitor of N-acetyltransferase 10, the key-player of RNA acetylation. We used the well-consolidated model of murine C2C12 cells cultivated on ultra-compliant gelatin hydrogels for long-term studies. The newly developed hydrogel scaffold promotes myotube alignment and maturation, mimicking the skeletal muscle biology observed in vivo. We differentiated C2C12 cells in low-serum conditions up to 16 days and treated them with the epi-drug Remodelin. At day 7 of differentiation, confocal images revealed that Remodelin prompted a lack of organization, proper morphology, and maturation of myotubes compared to the control. Marked twitching was neither visible upon Remodelin treatment, even in the late stage of differentiation. Remodelin downregulated the expression of protein markers of differentiation, but without any significant epi-modulation. Both transcriptomics and proteomics analyses confirmed that Remodelin effectively slowed down the process of myotube formation. RNAseq analysis revealed that the epi-drug down-regulated 749 genes, predominantly encoding proteins involved in muscle contraction, sarcomere organization, muscle structure development, and calcium ion binding. Proteomics analysis further unveiled that 37 significantly down-regulated proteins were related to extracellular matrix, cell-matrix adhesion, positive regulation of muscle cell differentiation, and calcium ion binding. Taken together, these results suggest that Remodelin exerts a broad effect on the regulatory networks of skeletal muscle differentiation.</div></div>","PeriodicalId":19135,"journal":{"name":"Neuromuscular Disorders","volume":"43 ","pages":"Article 104441.80"},"PeriodicalIF":2.7000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"271P Exploring the effects of the epi-drug Remodelin on murine myoblasts differentiation\",\"authors\":\"V. Sian , J. Sarparanta , A. Hentschel , P. Jonson , A. Roos , S. Natraj Gayathri , B. Udd , M. Savarese , A. Nebbioso\",\"doi\":\"10.1016/j.nmd.2024.07.089\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Skeletal muscle differentiation is a tightly controlled and elaborated process, that consists of alignment and fusion of myoblasts to form mature myotubes. A growing interest for epigenetics involvement in guiding muscle differentiation raised the attention on epi-modulators as pivotal regulators in this process. Our in vitro study aimed to investigate the potential effects of Remodelin in muscle differentiation. Remodelin is the inhibitor of N-acetyltransferase 10, the key-player of RNA acetylation. We used the well-consolidated model of murine C2C12 cells cultivated on ultra-compliant gelatin hydrogels for long-term studies. The newly developed hydrogel scaffold promotes myotube alignment and maturation, mimicking the skeletal muscle biology observed in vivo. We differentiated C2C12 cells in low-serum conditions up to 16 days and treated them with the epi-drug Remodelin. At day 7 of differentiation, confocal images revealed that Remodelin prompted a lack of organization, proper morphology, and maturation of myotubes compared to the control. Marked twitching was neither visible upon Remodelin treatment, even in the late stage of differentiation. Remodelin downregulated the expression of protein markers of differentiation, but without any significant epi-modulation. Both transcriptomics and proteomics analyses confirmed that Remodelin effectively slowed down the process of myotube formation. RNAseq analysis revealed that the epi-drug down-regulated 749 genes, predominantly encoding proteins involved in muscle contraction, sarcomere organization, muscle structure development, and calcium ion binding. Proteomics analysis further unveiled that 37 significantly down-regulated proteins were related to extracellular matrix, cell-matrix adhesion, positive regulation of muscle cell differentiation, and calcium ion binding. Taken together, these results suggest that Remodelin exerts a broad effect on the regulatory networks of skeletal muscle differentiation.</div></div>\",\"PeriodicalId\":19135,\"journal\":{\"name\":\"Neuromuscular Disorders\",\"volume\":\"43 \",\"pages\":\"Article 104441.80\"},\"PeriodicalIF\":2.7000,\"publicationDate\":\"2024-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Neuromuscular Disorders\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0960896624002530\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neuromuscular Disorders","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0960896624002530","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
271P Exploring the effects of the epi-drug Remodelin on murine myoblasts differentiation
Skeletal muscle differentiation is a tightly controlled and elaborated process, that consists of alignment and fusion of myoblasts to form mature myotubes. A growing interest for epigenetics involvement in guiding muscle differentiation raised the attention on epi-modulators as pivotal regulators in this process. Our in vitro study aimed to investigate the potential effects of Remodelin in muscle differentiation. Remodelin is the inhibitor of N-acetyltransferase 10, the key-player of RNA acetylation. We used the well-consolidated model of murine C2C12 cells cultivated on ultra-compliant gelatin hydrogels for long-term studies. The newly developed hydrogel scaffold promotes myotube alignment and maturation, mimicking the skeletal muscle biology observed in vivo. We differentiated C2C12 cells in low-serum conditions up to 16 days and treated them with the epi-drug Remodelin. At day 7 of differentiation, confocal images revealed that Remodelin prompted a lack of organization, proper morphology, and maturation of myotubes compared to the control. Marked twitching was neither visible upon Remodelin treatment, even in the late stage of differentiation. Remodelin downregulated the expression of protein markers of differentiation, but without any significant epi-modulation. Both transcriptomics and proteomics analyses confirmed that Remodelin effectively slowed down the process of myotube formation. RNAseq analysis revealed that the epi-drug down-regulated 749 genes, predominantly encoding proteins involved in muscle contraction, sarcomere organization, muscle structure development, and calcium ion binding. Proteomics analysis further unveiled that 37 significantly down-regulated proteins were related to extracellular matrix, cell-matrix adhesion, positive regulation of muscle cell differentiation, and calcium ion binding. Taken together, these results suggest that Remodelin exerts a broad effect on the regulatory networks of skeletal muscle differentiation.
期刊介绍:
This international, multidisciplinary journal covers all aspects of neuromuscular disorders in childhood and adult life (including the muscular dystrophies, spinal muscular atrophies, hereditary neuropathies, congenital myopathies, myasthenias, myotonic syndromes, metabolic myopathies and inflammatory myopathies).
The Editors welcome original articles from all areas of the field:
• Clinical aspects, such as new clinical entities, case studies of interest, treatment, management and rehabilitation (including biomechanics, orthotic design and surgery).
• Basic scientific studies of relevance to the clinical syndromes, including advances in the fields of molecular biology and genetics.
• Studies of animal models relevant to the human diseases.
The journal is aimed at a wide range of clinicians, pathologists, associated paramedical professionals and clinical and basic scientists with an interest in the study of neuromuscular disorders.